• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新定义 18577 例慢性阻塞性肺疾病患者中全球慢性阻塞性肺病倡议分类高症状负担的切点。

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

机构信息

Department of Research and Education, CIRO, Horn, The Netherlands.

Department of Research and Education, CIRO, Horn, The Netherlands; Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.

出版信息

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003.

DOI:10.1016/j.jamda.2017.09.003
PMID:29169740
Abstract

BACKGROUND

Patients with chronic obstructive pulmonary disease (COPD) can be classified into groups A/C or B/D based on symptom intensity. Different threshold values for symptom questionnaires can result in misclassification and, in turn, different treatment recommendations. The primary aim was to find the best fitting cut-points for Global initiative for chronic Obstructive Lung Disease (GOLD) symptom measures, with an modified Medical Research Council dyspnea grade of 2 or higher as point of reference.

METHODS

After a computerized search, data from 41 cohorts and whose authors agreed to provide data were pooled. COPD studies were eligible for analyses if they included, at least age, sex, postbronchodilator spirometry, modified Medical Research Council, and COPD Assessment Test (CAT) total scores.

MAIN OUTCOMES

Receiver operating characteristic curves and the Youden index were used to determine the best calibration threshold for CAT, COPD Clinical Questionnaire, and St. Georges Respiratory Questionnaire total scores. Following, GOLD A/B/C/D frequencies were calculated based on current cut-points and the newly derived cut-points.

FINDINGS

A total of 18,577 patients with COPD [72.0% male; mean age: 66.3 years (standard deviation 9.6)] were analyzed. Most patients had a moderate or severe degree of airflow limitation (GOLD spirometric grade 1, 10.9%; grade 2, 46.6%; grade 3, 32.4%; and grade 4, 10.3%). The best calibration threshold for CAT total score was 18 points, for COPD Clinical Questionnaire total score 1.9 points, and for St. Georges Respiratory Questionnaire total score 46.0 points.

CONCLUSIONS

The application of these new cut-points would reclassify about one-third of the patients with COPD and, thus, would impact on individual disease management. Further validation in prospective studies of these new values are needed.

摘要

背景

根据症状强度,慢性阻塞性肺疾病(COPD)患者可分为 A/C 或 B/D 组。症状问卷的不同阈值可能导致分类错误,并进而导致不同的治疗建议。主要目的是找到 Global initiative for chronic Obstructive Lung Disease(GOLD)症状测量的最佳拟合切点,以改良的 Medical Research Council 呼吸困难等级 2 或更高为参考点。

方法

在计算机检索后,对同意提供数据的 41 个队列的数据进行了汇总。如果 COPD 研究包括至少年龄、性别、支气管扩张后肺量测定、改良 Medical Research Council 呼吸困难量表和 COPD 评估测试(CAT)总分,则符合分析条件。

主要结果

使用受试者工作特征曲线和 Youden 指数来确定 CAT、COPD 临床问卷和圣乔治呼吸问卷总分的最佳校准阈值。随后,根据当前切点和新切点计算 GOLD A/B/C/D 的频率。

发现

共分析了 18577 例 COPD 患者[72.0%为男性;平均年龄 66.3 岁(标准差 9.6)]。大多数患者存在中重度气流受限(GOLD 肺功能分级 1 级 10.9%;2 级 46.6%;3 级 32.4%;4 级 10.3%)。CAT 总分的最佳校准阈值为 18 分,COPD 临床问卷总分为 1.9 分,圣乔治呼吸问卷总分为 46.0 分。

结论

应用这些新切点将重新分类约三分之一的 COPD 患者,从而影响个体疾病管理。需要进一步在前瞻性研究中验证这些新值。

相似文献

1
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.重新定义 18577 例慢性阻塞性肺疾病患者中全球慢性阻塞性肺病倡议分类高症状负担的切点。
J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003.
2
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.慢性阻塞性肺疾病全球倡议策略分类的真实世界特征与区分
Int J Chron Obstruct Pulmon Dis. 2014 May 28;9:551-61. doi: 10.2147/COPD.S62104. eCollection 2014.
3
GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.慢性阻塞性肺疾病的GOLD分类:症状与急性加重风险评估标准中的不一致性
COPD. 2017 Feb;14(1):1-6. doi: 10.1080/15412555.2016.1230844. Epub 2016 Oct 10.
4
Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.使用 COPD 评估测试 (CAT) 或改良版医学研究理事会呼吸困难评分 (mMRC) 对 COPD 组进行分类的差异:一项横断面分析。
BMC Pulm Med. 2013 Jun 3;13:35. doi: 10.1186/1471-2466-13-35.
5
Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.将新的慢性阻塞性肺疾病(COPD)全球倡议(GOLD)分期系统应用于美国基层医疗队列,并与医生和患者对严重程度的印象进行比较。
Int J Chron Obstruct Pulmon Dis. 2015 Jul 30;10:1477-86. doi: 10.2147/COPD.S78827. eCollection 2015.
6
Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.英国慢性阻塞性肺疾病的流行病学、严重程度及治疗(依据2013年慢性阻塞性肺疾病全球倡议)
Int J Chron Obstruct Pulmon Dis. 2015 May 13;10:925-37. doi: 10.2147/COPD.S82064. eCollection 2015.
7
Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.COPD 患者健康状况评分与 MRC 分级的比较:对 GOLD 2011 分类的影响。
Eur Respir J. 2013 Sep;42(3):647-54. doi: 10.1183/09031936.00125612. Epub 2012 Dec 20.
8
Modified Medical Research Council Dyspnea Scale in GOLD Classification Better Reflects Physical Activities of Daily Living.慢性阻塞性肺疾病全球倡议(GOLD)分类中改良的医学研究理事会呼吸困难量表能更好地反映日常生活中的身体活动情况。
Respir Care. 2018 Jan;63(1):77-85. doi: 10.4187/respcare.05636. Epub 2017 Sep 5.
9
Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.慢性阻塞性肺疾病(COPD)患者中与改良医学研究委员会分级相对应的COPD评估测试分数。
Korean J Intern Med. 2015 Sep;30(5):629-37. doi: 10.3904/kjim.2015.30.5.629. Epub 2015 Aug 27.
10
The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.不同评分系统预测慢性阻塞性肺疾病患者死亡率的能力:一项前瞻性队列研究。
Respiration. 2019;98(6):495-502. doi: 10.1159/000502826. Epub 2019 Oct 30.

引用本文的文献

1
Functional status in COPD: Comparison with healthy controls and impact of an exacerbation.慢性阻塞性肺疾病的功能状态:与健康对照的比较及急性加重的影响
Chron Respir Dis. 2025 Jan-Dec;22:14799731251358593. doi: 10.1177/14799731251358593. Epub 2025 Jul 8.
2
GOLD COPD Exacerbation History Categories and Disease Outcomes.慢性阻塞性肺疾病全球倡议(GOLD)的急性加重病史分类与疾病转归
JAMA Netw Open. 2024 Dec 2;7(12):e2445488. doi: 10.1001/jamanetworkopen.2024.45488.
3
Muscle fibre satellite cells are located at a greater distance from capillaries in patients with COPD compared with healthy controls.
与健康对照组相比,慢性阻塞性肺疾病(COPD)患者的肌纤维卫星细胞距离毛细血管更远。
ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00203-2024. eCollection 2024 Sep.
4
Pre- and post-vaccination characteristics and risk factors for COVID-19 outcomes in a Swedish population-based cohort of COPD patients.瑞典一项基于人群的慢性阻塞性肺疾病(COPD)患者队列中,接种新冠疫苗前后的特征及新冠病毒病(COVID-19)结局的风险因素。
ERJ Open Res. 2023 Jun 26;9(3). doi: 10.1183/23120541.00711-2022. eCollection 2023 May.
5
[What have we learned from the German COPD cohort COSYCONET and where do we go from here?].[我们从德国慢性阻塞性肺疾病队列研究COSYCONET中学到了什么,以及我们从这里将走向何方?]
Pneumologie. 2023 Feb;77(2):81-93. doi: 10.1055/a-1966-0848. Epub 2022 Dec 16.
6
Disease-Specific Anxiety in Chronic Obstructive Pulmonary Disease: Translation and Initial Validation of a Questionnaire.慢性阻塞性肺疾病中的疾病特异性焦虑:一份问卷的翻译与初步验证
Front Psychol. 2022 Jul 5;13:907939. doi: 10.3389/fpsyg.2022.907939. eCollection 2022.
7
Differences in Pulmonary and Extra-Pulmonary Traits between Women and Men with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病女性和男性在肺部及肺外特征上的差异。
J Clin Med. 2022 Jun 26;11(13):3680. doi: 10.3390/jcm11133680.
8
COPD profiles and treatable traits using minimal resources: identification, decision tree and stability over time.使用最少资源识别 COPD 表型和可治疗特征:决策树和随时间的稳定性。
Respir Res. 2022 Feb 14;23(1):30. doi: 10.1186/s12931-022-01954-6.
9
Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data.一年内肺功能和急性加重对慢性阻塞性肺疾病患者健康相关生活质量的影响:基于索赔数据的真实世界分析
Int J Chron Obstruct Pulmon Dis. 2021 Sep 21;16:2637-2651. doi: 10.2147/COPD.S313711. eCollection 2021.
10
Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD.基于登记的瑞典 COPD 患者队列中严重 COVID-19 的预测因素。
Eur Respir J. 2021 Nov 11;58(5). doi: 10.1183/13993003.01920-2021. Print 2021 Nov.